Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02310698 · ClinicalTrials.gov registry record
Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer Screening
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 487
- Enrollment target
NCT02310698: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02310698 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 487 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02310698 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 487 participants
- Enrollment target
Study Summary
Breast tumors are often detected on mammography but may be harder to see in women with dense breasts. This is why screening breast ultrasound is sometimes used as another test in women with dense breasts. Ultrasound has been shown to detect additional cancers that are not seen on regular mammography. Contrast Enhanced Digital Mammography (CEDM) is a FDA approved form of mammography. It is essentially a routine digital mammogram performed after iodine dye (the same that is used with CT scans) is injected into a vein in the arm. Like screening ultrasound, CEDM has been shown to detect breast cancers that are not seen on a regular mammogram. The purpose of this study is to compare whether CEDM or screening breast ultrasound is better at detecting cancer. Both will be done in this study and compared to one another.
Interventions
- DEVICE contrast enhanced digital mammography (CEDM)
- DEVICE whole breast screening ultrasound (WBUS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 487 participants |
| Start Date | 2014-12-02 |
| Est. Completion | 2025-03-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02310698
The ClinicalTrials.gov registry entry for NCT02310698 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 487 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which contrast enhanced digital mammography (CEDM) is the first listed.
NCT02310698 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02310698 about?
NCT02310698 is a clinical study titled "Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer Screening". Breast tumors are often detected on mammography but may be harder to see in women with dense breasts. This is why screening breast ultrasound is sometimes used as another test in women with dense breasts. Ultrasound has been shown to detect additional cancers that are not seen on regular mammography...
What is the current status of trial NCT02310698?
This trial is currently completed. The enrollment target is 487 participants. The study started on 2014-12-02. Estimated completion is 2025-03-26.
What interventions are being tested in trial NCT02310698?
The interventions under investigation include: contrast enhanced digital mammography (CEDM) (DEVICE), whole breast screening ultrasound (WBUS) (DEVICE).
Who is sponsoring clinical trial NCT02310698?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.